Report Detail
Global Rivastigmine Patch Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4608174 |
- 19 August, 2024 |
- Global |
- 89 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Rivastigmine (sold under the trade name Exelon among others) is a cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.
According to our (Global Info Research) latest study, the global Rivastigmine Patch market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Rivastigmine Patch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Rivastigmine Patch market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Rivastigmine Patch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Rivastigmine Patch market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Rivastigmine Patch market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rivastigmine Patch
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rivastigmine Patch market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Amneal Pharmaceuticals, Acino, Alvogen, Mylan N.V., Luye Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Rivastigmine Patch market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Once-daily Patch
Twice-weekly Patch
Market segment by Application
Alzheimer's Disease
Parkinson's Disease
Major players covered
Novartis
Amneal Pharmaceuticals
Acino
Alvogen
Mylan N.V.
Luye Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rivastigmine Patch product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rivastigmine Patch, with price, sales quantity, revenue, and global market share of Rivastigmine Patch from 2019 to 2024.
Chapter 3, the Rivastigmine Patch competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rivastigmine Patch breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Rivastigmine Patch market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rivastigmine Patch.
Chapter 14 and 15, to describe Rivastigmine Patch sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Rivastigmine Patch Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Once-daily Patch
- 1.3.3 Twice-weekly Patch
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Rivastigmine Patch Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Alzheimer's Disease
- 1.4.3 Parkinson's Disease
- 1.5 Global Rivastigmine Patch Market Size & Forecast
- 1.5.1 Global Rivastigmine Patch Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Rivastigmine Patch Sales Quantity (2019-2030)
- 1.5.3 Global Rivastigmine Patch Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Novartis
- 2.1.1 Novartis Details
- 2.1.2 Novartis Major Business
- 2.1.3 Novartis Rivastigmine Patch Product and Services
- 2.1.4 Novartis Rivastigmine Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Novartis Recent Developments/Updates
- 2.2 Amneal Pharmaceuticals
- 2.2.1 Amneal Pharmaceuticals Details
- 2.2.2 Amneal Pharmaceuticals Major Business
- 2.2.3 Amneal Pharmaceuticals Rivastigmine Patch Product and Services
- 2.2.4 Amneal Pharmaceuticals Rivastigmine Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Amneal Pharmaceuticals Recent Developments/Updates
- 2.3 Acino
- 2.3.1 Acino Details
- 2.3.2 Acino Major Business
- 2.3.3 Acino Rivastigmine Patch Product and Services
- 2.3.4 Acino Rivastigmine Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Acino Recent Developments/Updates
- 2.4 Alvogen
- 2.4.1 Alvogen Details
- 2.4.2 Alvogen Major Business
- 2.4.3 Alvogen Rivastigmine Patch Product and Services
- 2.4.4 Alvogen Rivastigmine Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Alvogen Recent Developments/Updates
- 2.5 Mylan N.V.
- 2.5.1 Mylan N.V. Details
- 2.5.2 Mylan N.V. Major Business
- 2.5.3 Mylan N.V. Rivastigmine Patch Product and Services
- 2.5.4 Mylan N.V. Rivastigmine Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Mylan N.V. Recent Developments/Updates
- 2.6 Luye Pharma
- 2.6.1 Luye Pharma Details
- 2.6.2 Luye Pharma Major Business
- 2.6.3 Luye Pharma Rivastigmine Patch Product and Services
- 2.6.4 Luye Pharma Rivastigmine Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Luye Pharma Recent Developments/Updates
3 Competitive Environment: Rivastigmine Patch by Manufacturer
- 3.1 Global Rivastigmine Patch Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Rivastigmine Patch Revenue by Manufacturer (2019-2024)
- 3.3 Global Rivastigmine Patch Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Rivastigmine Patch by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Rivastigmine Patch Manufacturer Market Share in 2023
- 3.4.3 Top 6 Rivastigmine Patch Manufacturer Market Share in 2023
- 3.5 Rivastigmine Patch Market: Overall Company Footprint Analysis
- 3.5.1 Rivastigmine Patch Market: Region Footprint
- 3.5.2 Rivastigmine Patch Market: Company Product Type Footprint
- 3.5.3 Rivastigmine Patch Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Rivastigmine Patch Market Size by Region
- 4.1.1 Global Rivastigmine Patch Sales Quantity by Region (2019-2030)
- 4.1.2 Global Rivastigmine Patch Consumption Value by Region (2019-2030)
- 4.1.3 Global Rivastigmine Patch Average Price by Region (2019-2030)
- 4.2 North America Rivastigmine Patch Consumption Value (2019-2030)
- 4.3 Europe Rivastigmine Patch Consumption Value (2019-2030)
- 4.4 Asia-Pacific Rivastigmine Patch Consumption Value (2019-2030)
- 4.5 South America Rivastigmine Patch Consumption Value (2019-2030)
- 4.6 Middle East & Africa Rivastigmine Patch Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Rivastigmine Patch Sales Quantity by Type (2019-2030)
- 5.2 Global Rivastigmine Patch Consumption Value by Type (2019-2030)
- 5.3 Global Rivastigmine Patch Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Rivastigmine Patch Sales Quantity by Application (2019-2030)
- 6.2 Global Rivastigmine Patch Consumption Value by Application (2019-2030)
- 6.3 Global Rivastigmine Patch Average Price by Application (2019-2030)
7 North America
- 7.1 North America Rivastigmine Patch Sales Quantity by Type (2019-2030)
- 7.2 North America Rivastigmine Patch Sales Quantity by Application (2019-2030)
- 7.3 North America Rivastigmine Patch Market Size by Country
- 7.3.1 North America Rivastigmine Patch Sales Quantity by Country (2019-2030)
- 7.3.2 North America Rivastigmine Patch Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Rivastigmine Patch Sales Quantity by Type (2019-2030)
- 8.2 Europe Rivastigmine Patch Sales Quantity by Application (2019-2030)
- 8.3 Europe Rivastigmine Patch Market Size by Country
- 8.3.1 Europe Rivastigmine Patch Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Rivastigmine Patch Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Rivastigmine Patch Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Rivastigmine Patch Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Rivastigmine Patch Market Size by Region
- 9.3.1 Asia-Pacific Rivastigmine Patch Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Rivastigmine Patch Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Rivastigmine Patch Sales Quantity by Type (2019-2030)
- 10.2 South America Rivastigmine Patch Sales Quantity by Application (2019-2030)
- 10.3 South America Rivastigmine Patch Market Size by Country
- 10.3.1 South America Rivastigmine Patch Sales Quantity by Country (2019-2030)
- 10.3.2 South America Rivastigmine Patch Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Rivastigmine Patch Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Rivastigmine Patch Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Rivastigmine Patch Market Size by Country
- 11.3.1 Middle East & Africa Rivastigmine Patch Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Rivastigmine Patch Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Rivastigmine Patch Market Drivers
- 12.2 Rivastigmine Patch Market Restraints
- 12.3 Rivastigmine Patch Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Rivastigmine Patch and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Rivastigmine Patch
- 13.3 Rivastigmine Patch Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Rivastigmine Patch Typical Distributors
- 14.3 Rivastigmine Patch Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Rivastigmine Patch. Industry analysis & Market Report on Rivastigmine Patch is a syndicated market report, published as Global Rivastigmine Patch Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Rivastigmine Patch market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
